Development of oculomics artificial intelligence for cardiovascular risk factors: A case study in fundus oculomics for HbA1c assessment and clinically relevant considerations for clinicians
- PMID: 39209216
- PMCID: PMC12303377
- DOI: 10.1016/j.apjo.2024.100095
Development of oculomics artificial intelligence for cardiovascular risk factors: A case study in fundus oculomics for HbA1c assessment and clinically relevant considerations for clinicians
Abstract
Artificial Intelligence (AI) is transforming healthcare, notably in ophthalmology, where its ability to interpret images and data can significantly enhance disease diagnosis and patient care. Recent developments in oculomics, the integration of ophthalmic features to develop biomarkers for systemic diseases, have demonstrated the potential for providing rapid, non-invasive methods of screening leading to enhance in early detection and improve healthcare quality, particularly in underserved areas. However, the widespread adoption of such AI-based technologies faces challenges primarily related to the trustworthiness of the system. We demonstrate the potential and considerations needed to develop trustworthy AI in oculomics through a pilot study for HbA1c assessment using an AI-based approach. We then discuss various challenges, considerations, and solutions that have been developed for powerful AI technologies in the past in healthcare and subsequently apply these considerations to the oculomics pilot study. Building upon the observations in the study we highlight the challenges and opportunities for advancing trustworthy AI in oculomics. Ultimately, oculomics presents as a powerful and emerging technology in ophthalmology and understanding how to optimize transparency prior to clinical adoption is of utmost importance.
Keywords: Artificial intelligence; Machine learning; Oculomics; Ophthalmology; Reliability; Trustworthy.
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
Figures












Similar articles
-
Application of ChatGPT-4 to oculomics: a cost-effective osteoporosis risk assessment to enhance management as a proof-of-principles model in 3PM.EPMA J. 2024 Aug 28;15(4):659-676. doi: 10.1007/s13167-024-00378-0. eCollection 2024 Dec. EPMA J. 2024. PMID: 39635018
-
Trust, Trustworthiness, and the Future of Medical AI: Outcomes of an Interdisciplinary Expert Workshop.J Med Internet Res. 2025 Jun 2;27:e71236. doi: 10.2196/71236. J Med Internet Res. 2025. PMID: 40455564 Free PMC article.
-
Integrating artificial intelligence in healthcare: applications, challenges, and future directions.Future Sci OA. 2025 Dec;11(1):2527505. doi: 10.1080/20565623.2025.2527505. Epub 2025 Jul 4. Future Sci OA. 2025. PMID: 40616302 Free PMC article. Review.
-
The impact of artificial intelligence on the endoscopic assessment of inflammatory bowel disease-related neoplasia.Therap Adv Gastroenterol. 2025 Jun 23;18:17562848251348574. doi: 10.1177/17562848251348574. eCollection 2025. Therap Adv Gastroenterol. 2025. PMID: 40556746 Free PMC article. Review.
-
Perspectives of Health Care Professionals on the Use of AI to Support Clinical Decision-Making in the Management of Multiple Long-Term Conditions: Interview Study.J Med Internet Res. 2025 Jul 4;27:e71980. doi: 10.2196/71980. J Med Internet Res. 2025. PMID: 40613609 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous